Clinical Trial: An Open-label Study to Assess the Safety and Efficacy of SYMVESS(R) as a Vascular Conduit in Adolescents With Extremity Arterial Injury.

U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07762313) titled 'An Open-label Study to Assess the Safety and Efficacy of SYMVESS(R) as a Vascular Conduit in Adolescents With Extremity Arterial Injury.' on Aug. 03.

Brief Summary: The goal of this study is to assess the safety and efficacy of Symvess in sexually mature adolescents (17 years of age or younger) who require a vascular conduit to repair an extremity arterial injury when autologous vein graft is not available.

The main questions the study aims to answer are:

Safety and tolerability of Symvess in adolescent patients? Determine patency of Symvess over 12-months Evaluate the long-term amputation-free rate Determine the ability of Symves...